We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Millennium Urges FDA to Require Human Trials for Fresenius Drug
Millennium Urges FDA to Require Human Trials for Fresenius Drug
September 20, 2013
The FDA should not approve Fresenius Kabi’s 505(b)(2) NDA for the injectable cancer treatment bortezomib before it has been tested in humans and shown to be safe and effective, Millennium Pharmaceuticals charges in a citizen petition.